Successful treatment of refractory cutaneous R osai– D orfman disease with vincristine
2014; Wiley; Volume: 42; Issue: 1 Linguagem: Inglês
10.1111/1346-8138.12694
ISSN1346-8138
AutoresPing Liu, Pei Wang, Juan Du, Jianzhong Zhang,
Tópico(s)Parvovirus B19 Infection Studies
ResumoThe Journal of DermatologyVolume 42, Issue 1 p. 97-98 Letter to the Editor Successful treatment of refractory cutaneous Rosai–Dorfman disease with vincristine Ping Liu, Ping Liu Department of Dermatology, Peking University People's Hospital, Xicheng District, Beijing, ChinaSearch for more papers by this authorPei Wang, Pei Wang Department of Dermatology, Peking University People's Hospital, Xicheng District, Beijing, ChinaSearch for more papers by this authorJuan Du, Juan Du Department of Dermatology, Peking University People's Hospital, Xicheng District, Beijing, ChinaSearch for more papers by this authorJianzhong Zhang, Corresponding Author Jianzhong Zhang Department of Dermatology, Peking University People's Hospital, Xicheng District, Beijing, ChinaCorrespondence: Jianzhong Zhang, M.D., Department of Dermatology, Peking University People's Hospital, 11 Xizhimen South Street, Xicheng District, Beijing 100044, China. Email: [email protected]Search for more papers by this author Ping Liu, Ping Liu Department of Dermatology, Peking University People's Hospital, Xicheng District, Beijing, ChinaSearch for more papers by this authorPei Wang, Pei Wang Department of Dermatology, Peking University People's Hospital, Xicheng District, Beijing, ChinaSearch for more papers by this authorJuan Du, Juan Du Department of Dermatology, Peking University People's Hospital, Xicheng District, Beijing, ChinaSearch for more papers by this authorJianzhong Zhang, Corresponding Author Jianzhong Zhang Department of Dermatology, Peking University People's Hospital, Xicheng District, Beijing, ChinaCorrespondence: Jianzhong Zhang, M.D., Department of Dermatology, Peking University People's Hospital, 11 Xizhimen South Street, Xicheng District, Beijing 100044, China. Email: [email protected]Search for more papers by this author First published: 25 November 2014 https://doi.org/10.1111/1346-8138.12694Citations: 10Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. References 1Rosai J, Dorfman RF. Sinus histiocytosis with massive lymphadenopathy. A newly recognized benign clinicopathological entity. Arch Pathol 1969; 87: 63–70. CASPubMedWeb of Science®Google Scholar 2Landim FM, Rios Hde O, Costa CO, Feitosa RG, Rocha Filho FD, Costa AA. Cutaneous Rosai-Dorfman disease. An Bras Dermatol 2009; 84: 275–278. 10.1590/S0365-05962009000300010 Google Scholar 3Picco P, Buoncompagni A, Pistoia V et al. Diagnostic difficulties and positive therapeutic response in a patient with sinus histiocytosis with massive lymphadenopathy. Eur J Pediatr 1993; 152: 699. Google Scholar 4Maklad AM, Bayoumi Y, Tunio M, Alshakweer W, Dahar MA, Akbar SA. Steroid-resistant extranodal rosai-dorfman disease of cheek mass and ptosis treated with radiation therapy. Case Rep Hematol 2013; 2013: 428297. Google Scholar Citing Literature Volume42, Issue1Special Issue: Special Issue: Pemphigus updates from around the world (pages 1‐41)January 2015Pages 97-98 ReferencesRelatedInformation
Referência(s)